BibTex format
@article{Celutkiene:2020:10.1002/ejhf.1957,
author = {Celutkiene, J and Pudil, R and Lopez-Fernandez, T and Grapsa, J and Nihoyannopoulos, P and Bergler-Klein, J and Cohen-Solal, A and Farmakis, D and Tocchetti, CG and von, Haehling S and Barberis, V and Flachskampf, FA and Ceponiene, I and Haegler-Laube, E and Suter, T and Lapinskas, T and Prasad, S and de, Boer RA and Wechalekar, K and Anker, MS and Iakobishvili, Z and Bucciarelli-Ducci, C and Schulz-Menger, J and Cosyns, B and Gaemperli, O and Belenkov, Y and Hulot, J-S and Galderisi, M and Lancellotti, P and Bax, J and Marwick, TH and Chioncel, O and Jaarsma, T and Mullens, W and Piepoli, M and Thum, T and Heymans, S and Mueller, C and Moura, B and Ruschitzka, F and Zamorano, JL and Rosano, G and Coats, AJS and Asteggiano, R and Seferovic, P and Edvardsen, T and Lyon, AR},
doi = {10.1002/ejhf.1957},
journal = {EUROPEAN JOURNAL OF HEART FAILURE},
pages = {1504--1524},
title = {Role of cardiovascular imaging in cancer patients receiving cardiotoxic therapies: a position statement on behalf of the Heart Failure Association (HFA), the European Association of Cardiovascular Imaging (EACVI) and the Cardio-Oncology Council of the European Society of Cardiology (ESC)},
url = {http://dx.doi.org/10.1002/ejhf.1957},
volume = {22},
year = {2020}
}